Eileen M. O'Reilly · researcher ORCID ID = 0000-0002-8076-9199 · YYNN

Eileen M. O'Reilly

? TBD

researcher ORCID ID = 0000-0002-8076-9199

Ratings 0

Nobody has rated this yet. Be the first!

Works 2

Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology

scientific article published on 01 August 2017

Phase III study comparing gemcitabine plus cetuximab versus gemcitabine in patients with advanced pancreatic adenocarcinoma: Southwest Oncology Group-directed intergroup trial S0205

scientific article

Lists 0